A muscarinic DREADD agonist
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

JHU37152

Item No. 39532

Technical Information
Formal Name
8-chloro-11-(4-ethyl-1-piperazinyl)-1-fluoro-5H-dibenzo[b,e][1,4]diazepine
CAS Number
2369979-67-7
Molecular Formula
C19H20ClFN4
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: SolubleMethanol: Soluble
SMILES
FC1=CC=CC2=C1C(N3CCN(CC3)CC)=NC4=CC(Cl)=CC=C4N2
InChi Code
InChI=1S/C19H20ClFN4/c1-2-24-8-10-25(11-9-24)19-18-14(21)4-3-5-16(18)22-15-7-6-13(20)12-17(15)23-19/h3-7,12,22H,2,8-11H2,1H3
InChi Key
NZMZJNNWMSYDNX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    JHU37152 is an activator of designer receptors exclusively activated by designer drugs (DREADDs) derived from human muscarinic acetylcholine receptors (mAChRs).1 It binds to hM3Dq and hM4Di receptors (Kis = 1.8 and 8.7 nM, respectively) and induces Gαo1 activation in HEK293 cells expressing hM3Dq or hM4Di (EC50s = 5 and 0.5 nM, respectively). In vivo, JHU37152 (1 mg/kg) inhibits locomotor activity in D1-hM3Dq and D1-hM4Di transgenic mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bonaventura, J., Eldridge, M.A.G., Hu, F., et alHigh-potency ligands for DREADD imaging and activation in rodents and monkeys. Nat. Commun. 10(1), 4627 (2019).